Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [<sup>11</sup>C]CB184, in healthy human volunteers.

Sakata, Muneyuki; Ishibashi, Kenji; Imai, Masamichi; Wagatsuma, Kei; Ishii, Kenji; Hatano, Kentaro; Ishiwata, Kiichi; Toyohara, Jun

Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [¹¹C]CB184, in healthy human volunteers.

Sakata, Muneyuki; Ishibashi, Kenji; Imai, Masamichi; Wagatsuma, Kei; Ishii, Kenji; Hatano, Kentaro; Ishiwata, Kiichi; Toyohara, Jun.

Afiliação

Sakata M; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, 173-0015, Tokyo, Japan.
Ishibashi K; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, 173-0015, Tokyo, Japan.
Imai M; Department of Radiology, Toranomon Hospital, Tokyo, Japan.
Wagatsuma K; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, 173-0015, Tokyo, Japan.
Ishii K; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, 173-0015, Tokyo, Japan.
Hatano K; Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Ishiwata K; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, 173-0015, Tokyo, Japan.
Toyohara J; Institute of Cyclotron and Drug Discovery Research, Southern TOHOKU Research Institute for Neuroscience, Koriyama, Japan.

EJNMMI Res ; 7(1): 26, 2017 Dec.

Article em En | MEDLINE | ID: mdl-28337723

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Idioma: En Revista: EJNMMI Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google